Newsroom | 2767 results

Sorted by: Latest

Veterinary
-

FDA Conditionally Approves Merck Animal Health's EXZOLT™ CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis)

RAHWAY, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration (FDA) has granted a conditional approval for EXZOLT™ CATTLE-CA1 (fluralaner topical solution). This innovative product is in the newest class of parasiticides known as isoxazolines. The pour-on solution is effective for the prevention and treatment of infest...
-

Roseman University Appoints Dr. Christina V. Tran as Executive Associate Dean for Proposed College of Veterinary Medicine

HENDERSON, Nev.--(BUSINESS WIRE)--Roseman University has appointed Christina V. Tran, DVM, as executive associate dean of the university’s proposed College of Veterinary Medicine....
-

Otto Partners with Industry Leaders to Provide Free Access to AI Scribe

AUSTIN, Texas--(BUSINESS WIRE)--Otto, the veterinary technology company trusted by more than 5,000 clinics, today announced that Hill’s Pet Nutrition and The Veterinary Cooperative (TVC) are partnering with Otto to provide clinics with access free of charge to Otto AI Scribe, expanding the availability of veterinary-specific documentation tools to Hill’s Connect clinic partners and to TVC member clinics. This collaboration marks a major step forward in giving veterinary teams access to the indu...
-

Small Door Veterinary Strengthens Executive Team as It Enters Next Phase of Growth

NEW YORK--(BUSINESS WIRE)--Small Door Veterinary, the membership-based veterinary care company reimagining the pet health experience, today announced that it has hired Mikhayl Alam as its new Chief Financial Officer and Collin Russell as Head of People. The additions come on the heels of a record year of profitability and a $55 million capital raise, positioning the company to accelerate expansion with six new locations slated to open next year. Alam brings over 15 years of experience driving g...
-

FCPT Announces Acquisition of a VCA Animal Hospital Property for $5.8 Million

MILL VALLEY, Calif.--(BUSINESS WIRE)--FCPT Announces Acquisition of a VCA Animal Hospital Property for $5.8 Million...
-

Zoetis Highlights R&D Leadership and Long-Term Growth Opportunity at Innovation Webcast

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS), the world’s leading animal health company, will host an Innovation Webcast today at 8:30 a.m. ET to provide an update on its proven innovation model, robust and diversified R&D pipeline, and upcoming growth catalysts as the company continues pioneering the future of animal health. “The pace of animal health innovation is accelerating alongside a growing appreciation for the essential role animals play in our lives and communities....
-

Mountain Valley MD Confirms Positive Agrarius Agricultural Trial Results, Advancing Toward Commercialization

TORONTO--(BUSINESS WIRE)--Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTC: MVMDF) (FRA: 20MP) is pleased to provide an update on recent Agrarius™ agricultural product trial results, including key outcomes from its ongoing citrus field trials in Brazil and cattle pasture grass trials in Colombia. These trial programs are intended to support the Company’s customer product adoption strategy and commercial development initiatives for its licensed Agrarius agricultural pl...
-

Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. today announced that the European Commission has granted the company marketing authorization for Lenivia® (izenivetmab) for the reduction of pain associated with osteoarthritis (OA) in dogs. Lenivia is a new antibody therapy that reduces OA pain in dogs for three months with one injection through its novel binding properties to nerve growth factor (NGF), recognized as an important mediator of pain and inflammation. Lenivia is built on a decade of s...
-

NEL动物医学基金会成为韩国首家完成100例开胸手术的机构

韩国安养--(BUSINESS WIRE)--(美国商业资讯)-- 韩国NEL动物医学基金会(理事长:Eom Tae-heum医生)宣布,于11月25日成功完成第100例犬类开胸手术,成为韩国首家达到该里程碑的兽医机构。这一成就距基金会2023年底成功完成首例二尖瓣修复手术仅两年,标志着高水平兽医胸外科手术进入了一个新时代。 过去,犬类心脏病被视为一种慢性疾病,只能通过药物治疗。然而,NEL动物医学基金会利用体外循环(CPB)技术,树立了外科治疗的新标杆。基金会展现出前所未有的增长势头,预计在2025年底将达到每周四台手术的峰值水平。 除手术量之外,NEL动物心脏团队也取得了卓越的临床疗效。2025年下半年,该团队的手术成功率超过97%,36只患病的动物中有35只成功出院。值得一提的是,所有动物均完全停止服用心脏药物,恢复了正常生活。 基金会还成功完成了一系列高难度病例,在全球范围内证明了其卓越的技术实力,其中包括: 为一只体重仅1.6公斤的超小型犬进行手术。 全球首例复杂室间隔缺损(VSD)手术矫正。 感染性心内膜炎(IE)的外科治疗。 这些成功源于基金会理事长Eom Tae-heu...
-

NEL Animal Medical Foundation Becomes First in Korea to Achieve 100 Open-Heart Surgeries

ANYANG, South Korea--(BUSINESS WIRE)--NEL Animal Medical Foundation has performed 100 canine open-heart surgeries, opening a new chapter in high-level veterinary thoracic surgery....